SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFS14A - Definitive proxy statement for special meeting:
SEC Accession No. 0000318306-97-000002
Filing Date
1997-02-05
Accepted
1997-02-05 00:00:00
Documents
1
Period of Report
1997-01-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 DEFS14A 42315
  Complete submission text file 0000318306-97-000002.txt   43952
Mailing Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 210 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFS14A | Act: 34 | File No.: 000-09314 | Film No.: 97518569
SIC: 2834 Pharmaceutical Preparations